Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
Clinical trial NCT00245960 · COMPLETED
Trial details
- NCT number
- NCT00245960
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-27
- Primary completion
- 2008-03-29
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.